Back

Clinical profile of patients undergoing percutaneous stellate ganglion block for electrical storm and association with antiarrhythmic efficacy

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Sudden cardiac death: what’s new? Clinical ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Arianna Morena

Hospital Citta Della Salute e della Scienza di Torino, Turin (Italy)

7 More presentations in this session

Presentation thumbnail
Resuscitation of people with a do-not-resuscitate order: when does it happen and what are the outcomes?
Doctor E. Paratz (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Implications of age and sex on the diagnostic yield of sudden arrhythmic death syndrome
Associate Professor B. Gray (Camperdown, AU)
Abstract Slides
Presentation thumbnail
Post-ROsc ecG pREdictS Survival after out-of hospital cardiac arrest: validation of the PROGRESS score
Ms C. Lopiano (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Cardiovascular etiologies and risk factors of survival outcomes after resuscitation for out-of-hospital cardiac arrest: data from the KoCARC registry
Professor J. Choi (Seoul, KR)
Abstract Slides
Presentation thumbnail
Survivability of young sudden cardiac arrest by aetiology: insights from a state-wide adjudicated cardiac arrest registry
Doctor L. Fahy (Fitzroy, AU)
Abstract Slides

Access the full session

Session thumbnail
Sudden cardiac death: what’s new?

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of ultrasound guided stellate ganglion block: developing new clinical indications beyond electrical storm
thumbnail
Congress Presentation
Clinical determinants of percutaneous stellate ganglion block (PSGB) effectiveness in patients with electrical storm
thumbnail
Congress Presentation
The quiet after the storm: a case of percutaneous stellate ganglion blockade after acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources